| Ticker Details |
BioLife Solutions, Inc.
BioLife Solutions Inc manufactures proprietary and generic cGMP biopreservation media products, generic formulations of blood stem cell freezing media products, custom product formulation packaging services and contract aseptic manufacturing formulation.
|
| IPO Date: |
October 1, 2002 |
| Sector: |
Healthcare |
| Industry: |
Health Care Equipment and Supplies |
| Market Cap: |
$1.17B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.47 | 2.94%
|
| Avg Daily Range (30 D): |
$0.52 | 2.40%
|
| Avg Daily Range (90 D): |
$0.48 | 2.22%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.2M |
| Avg Daily Volume (30 D): |
.39M |
| Avg Daily Volume (90 D): |
.35M |
| Trade Size |
| Avg Trade Size (Sh.): |
74 |
| Avg Trade Size (Sh.) (30 D): |
53 |
| Avg Trade Size (Sh.) (90 D): |
51 |
| Institutional Trades |
| Total Institutional Trades: |
1,620 |
| Avg Institutional Trade: |
$1.56M |
| Avg Institutional Trade (30 D): |
$1.6M |
| Avg Institutional Trade (90 D): |
$1.37M |
| Avg Institutional Trade Volume: |
.06M |
| Avg Institutional Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$1.58M |
| Avg Closing Trade (30 D): |
$1.52M |
| Avg Closing Trade (90 D): |
$1.48M |
| Avg Closing Volume: |
60.2K |
|
|
| Financials |
| |
TTM |
Q1 2026 |
Q4 2025 |
|
Basic EPS
|
$-.06
|
$.02
|
$.24
|
|
Diluted EPS
|
$-.07
|
$.02
|
$.23
|
|
Revenue
|
$99.77M
|
$27.5M
|
$18.79M
|
|
Gross Profit
|
$64.81M
|
$17.5M
|
|
|
Net Income / Loss
|
$-2.96M
|
$1.19M
|
$11.07M
|
|
Operating Income / Loss
|
$-15.36M
|
$.03M
|
$1.35M
|
|
Cost of Revenue
|
$36.85M
|
$10M
|
|
|
Net Cash Flow
|
$-44.12M
|
$-10.22M
|
$3.56M
|
|
PE Ratio
|
|
|
|
|
|
|
